Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Approved

STANDARD

TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Fresenius Kabi Deutschland Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 21, 2023
Approval ID: b01bee8635176518
Company: Fresenius Kabi Deutschland Gmbh
Type: Standard

Approval Details

Approval Id: b01bee8635176518
Drug Cima Aemps Name: TYENNE 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number: 1231754010
Holder Company Name: Fresenius Kabi Deutschland Gmbh
Marketing Company Name: Fresenius Kabi España, S.A.U.
Holder Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh
Authorization Date: 2023-09-21
Dosage Form: SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose: 162 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Fresenius Kabi Deutschland Gmbh
Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh

Company Information

Pharmaceutical Company Name: Fresenius Kabi Deutschland Gmbh
Country Name: Sweden
Address: Utländsk Adr - Foreign Addr
Website: http://www.fresenius-kabi.com

Active Ingredients

TOCILIZUMAB

162 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 21, 2023

Approval ID

b01bee8635176518

Type

Standard

Back to CIMA-AEMPS Approvals